 | Voyager Therapeutics, Inc. | |||
| NMS : VYGR || Location: United States | ||||
$7.65+0.08 (+1.06%) |
0.37 M | 7.57 - 7.78 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.331 M |
| March 15, 2024 | 2.312 M |
| Feb. 29, 2024 | 2.262 M |
| Feb. 15, 2024 | 2.146 M |
| Jan. 31, 2024 | 1.969 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.29 | 1.25 | 524.74% |
| 09/30/2023 | -0.59 | -0.59 | 0.49% |
| 06/30/2023 | -0.58 | -0.51 | 12.05% |
| 03/31/2023 | 0.79 | 2.94 | 273.52% |
| 12/31/2022 | -0.56 | -0.61 | -9.30% |
VYGR Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 54.301M | Shares Float | 36.936M |
| Short Float | 3.331M | Market Cap | 415.40M |
| Institution ownership | 49.05% | Insider ownership | 17.289% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | 2.97 | Forward EPS | -1.73 |